Filter News
Area of Research
- (-) Biology and Environment (12)
- Advanced Manufacturing (2)
- Clean Energy (30)
- Computer Science (2)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (14)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (2)
- Materials (68)
- Materials Characterization (1)
- Materials for Computing (8)
- Materials Under Extremes (1)
- National Security (13)
- Neutron Science (44)
- Nuclear Science and Technology (8)
- Sensors and Controls (1)
- Supercomputing (31)
News Topics
- (-) Advanced Reactors (1)
- (-) Artificial Intelligence (3)
- (-) Materials Science (4)
- (-) Microscopy (3)
- (-) Neutron Science (3)
- (-) Nuclear Energy (1)
- (-) Physics (1)
- (-) Polymers (1)
- (-) Security (1)
- 3-D Printing/Advanced Manufacturing (7)
- Big Data (1)
- Bioenergy (9)
- Biology (17)
- Biomedical (5)
- Biotechnology (5)
- Buildings (2)
- Chemical Sciences (8)
- Climate Change (7)
- Composites (3)
- Computer Science (5)
- Coronavirus (7)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (5)
- Environment (13)
- Fusion (1)
- Grid (1)
- High-Performance Computing (5)
- Isotopes (2)
- Machine Learning (2)
- Materials (10)
- Molten Salt (1)
- Nanotechnology (5)
- National Security (1)
- Net Zero (1)
- Partnerships (5)
- Simulation (4)
- Summit (3)
- Sustainable Energy (4)
- Transformational Challenge Reactor (1)
- Transportation (2)
Media Contacts
![ORNL Sign](/sites/default/files/styles/list_page_thumbnail/public/2020-11/ORNLsign.jpg?h=22d0129c&itok=YoZbTjCS)
Seven ORNL scientists have been named among the 2020 Highly Cited Researchers list, according to Clarivate, a data analytics firm that specializes in scientific and academic research.
![An organic solvent and water separate and form nanoclusters on the hydrophobic and hydrophilic sections of plant material, driving the efficient deconstruction of biomass. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-11/dark_image_small.png?h=2e111cc1&itok=drKqW05b)
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.